Kangmei Pharmaceutical Co. Ltd Financials

Market Capitalization CN¥26.48 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	99.50
Forward PE
Price to Sales TTM	CN¥5.01
Price to Book MRQ	CN¥3.69
Enterprise to Revenue	4.82
Enterprise to EBITDA	-351.84

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	0.18%
Operating Margin	1.14%
Return on Assets TTM	-1.58%
Return on Equity TTM	0.17%

Income Statement

Revenue TTM	CN¥5,287,195,648
Revenue per Share TTM	CN¥0.36
Quarterly Revenue Growth	8.20%
Gross Profit TTM	CN¥715,506,752
EBITDA	CN¥500,424,974
Net Income to Common TTM	CN¥9,608,145
Diluted EPS TTM	CN¥0.00
Quarterly Earnings Growth YoY	13.80%

Balance Sheet

Total Cash MRQ	CN¥894,222,144
Total Cash per Share MRQ	CN¥0.07
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	2.03
Current Ratio MRQ	1.19
Book Value per Share MRQ	CN¥0.52

Cash Flow

Operating Cash Flow TTM	CN¥-196,459,968
Levered Free Cash Flow TTM	CN¥1,395,881,344

600518 Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	13,863,866,690
Float Shares	10,024,823,365
Avg 10 Volume	129,937,143
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	27.37%
% Held by Institutions	7.16%

Stock Price Summary

Beta	0.72
Fifty Two Week Low	CN¥1.68
Fifty Two Week High	CN¥2.95
Fifty Two Week Change	-8.42%
Day 50 MA	CN¥1.95
Day 200 MA	CN¥2.14

Dividends and Splits

Forward Annual Dividend Rate	CN¥0.10
Forward Annual Dividend Yield	5.05%
Trailing Annual Dividend Rate	CN¥0.02
Trailing Annual Dividend Yield	1.26%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date	2019-08-28
Last Split Factor
Last Split Date	2015-06-16